Teddi Dowling
Nurse Practitioner · Pierre, SDNPI 1457019283
Payments from drug & device makers
Across 73 payments — averaging $17.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$150
- Novartis$134
- Bristol Myers Squibb$127
- Merck$85
- Daiichi Sankyo Inc.$83
- Pfizer$71
- plus $620 from 22 others
What the payments were for
- Food & beverage$1,271100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 8 | $150 |
| Novartis | 8 | $134 |
| Bristol Myers Squibb | 8 | $127 |
| Merck | 4 | $85 |
| Daiichi Sankyo Inc. | 5 | $83 |
| Pfizer | 4 | $71 |
| Gilead(2 entities) | 4 | $67 |
| Beigene USA, Inc. | 3 | $65 |
| Lilly USA, LLC | 3 | $55 |
| Puma Biotechnology, Inc. | 3 | $51 |
| Astellas Pharma US Inc | 3 | $45 |
| Seagen Inc. | 3 | $38 |
| E.r. Squibb & Sons, L.L.C. | 2 | $35 |
| AbbVie | 1 | $26 |
| Geron Corporation | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Myovant Sciences Inc. | 1 | $20 |
| Array Biopharma Inc | 1 | $18 |
| Eisai Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Axonics, Inc. | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| AstraZeneca | 1 | $14 |
| Immunogen, Inc. | 1 | $13 |
| AVEO Pharmaceuticals, Inc. | 1 | $13 |
| Sanofi | 1 | $12 |
How this compares
$1,271 in reported general payments places this provider in the 80th percentile of 504 nurse practitioner providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RevlimidLenalidomide | 16 | $303,134 |
| XtandiEnzalutamide | 12 | $120,772 |
| Ondansetron OdtOndansetron | 24 | $618 |
| Letrozole | 17 | $497 |
| Dexamethasone | 17 | $460 |
| Morphine Sulfate ErMorphine Sulfate | 11 | $362 |
| Potassium Chloride | 18 | $250 |
| Gabapentin | 30 | $243 |
| Acyclovir | 30 | $242 |
| Oxycodone Hcl | 15 | $150 |
| Duloxetine Hcl | 16 | $138 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $69 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bristol Myers SquibbRevlimid | $127 | $303,13416 claims |
| Astellas Pharma US IncXtandi | $45 | $120,77212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 504 nurse practitioner providers in South Dakota.
Other nurse practitioner in Pierre
- Danielle EtzkornPierre$4K
- Jamie BuschSioux Falls$60K
- Jessica SlabaSioux Falls$41K
- Christopher NelsonSioux Falls$35K
- Katherine EricsonSioux Falls$13K
- Rosa EytonAberdeen$7K
- Kristi GlanzerHuron$6K
- Roger DeraadRapid City$6K
- Gabrielle PriceSioux Falls$5K
- Jacqueline KelleySioux Falls$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.